US Patent Issued to Atai Therapeutics on July 1 for "Aminotetraline activators of serotonin receptors" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,570, issued on July 1, was assigned to Atai Therapeutics Inc. (New York).

"Aminotetraline activators of serotonin receptors" was invented by Glenn Short (Scituate, Mass.), Robert B. Perni (Marlborough, Mass.) and Tanweer A. Khan (Bridgewater, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula (I), (I-A), (I-B), (II), (II-A), (II-B), (III), (III-A), (IV), and (IV-A), or pharmaceutically acceptable salt thereof described herein. Also provided herein are pharmaceutical compositions comprising a compound Formula (I), (I-A), (I-B), (II), (II-A), (II-B), (III), (III-A), (IV), and (IV-A), or pharmaceutically accepta...